Introduction ： Yu Zhiqiang, Professor, doctoral supervisor, Director of Laboratory Medicine Center of the 10th Affiliated Hospital of Southern Medical University (Dongguan People's Hospital); Director of the Laboratory Section, Dongguan Cancer Clinical Medical Research Institute executive deputy director. His research interests are cancer diagnosis and treatment, cancer marker screening and molecular diagnostic kit development. Guided by the combination of basic research and clinical practice, he conducts research related to tumor diagnosis and treatment with directors of multiple clinical departments. His research interests are cancer diagnosis and treatment, cancer marker screening and molecular diagnostic kit development. Since 2015, it has undertaken 4 National Natural Science funds and more than 10 municipal projects in Guangdong Province. In recent years, he has published more than 60 SCI papers in Adv. Mater, JACS, ACS Nano, Angew, Adv. Funct.Mater, Nano Lett and other international journals as one author or corresponding author, 11 of which are ESI high citation papers. In the past three years, more than 30 papers with an impact factor of >10 have been published, and the total number of papers has been cited for about 7630 times, with an H-factor of 52. Authorized 2 invention patents, converted 1 patent, deputy editor wrote 1 monograph. Ranking of the World's Top 100,000 scientists (2021, 2022, 2023). Senior editorial Board member of Chinese Chemical Express (CCL, IF=8.50), editorial board member of Asian Journal of Pharmaceutical Sciences (AJPS, IF=9.35), Editorial Board member of Acta Pharmacologica Sinica B (APSB, IF=14.95), associate editor of View Medicine.